Dominican Republic

Dominican Republic

Dominican Republic

Dominican Republic

Clinical Trial Application

Dominican Republic Clinical Trial Quote Request

Dominican Republic Due Diligence Form - Spanish (Persona Juridica)

Mandated Coverage

Yes and No. Clinical Trial Insurance is not compulsory, however, it is made mandatory as part of the MoH submission.

Standard Limits

n/a

Tail Coverage

n/a

Data Required to Quote

• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Protocol Title in Spanish
• Legal Representative in Dominican Republic or Local CRO details (Contact Person Name, Address, Telephone Number and E-Mail Address)
• No refund for policy cancellation

Due to strict Anti-Money Laundering laws, the Legal Representative (typically your local CRO) will be responsible for providing the following documents:
(i) Due Diligence Form, available in Spanish only (to be completed by US Sponsor and each named insured, including additional insureds)
(ii) Fiscal ID certificate
(iii) Mercantile Registry
(iv) ID of the person acting on behalf of the Legal Representative
(v) Certificate of final beneficiary

Process in the Dominican Republic is SLOW, so please allow for additional time - minimum 1 month before receipt of documentation after binding coverage

Nigeria

Nigeria

Clinical Trial Application

Nigeria Clinical Trial Quote Request

Clinical Trials Quote Request

Mandated Coverage

Yes. It is recommended that Sponsor use an experienced or local CRO in Nigeria

Standard Limits

n/a

Tail Coverage

n/a

Data Required to Quote

Process is SLOW in Nigeria. Please allow for additional time. Submission should be made at least one month before documents are required


• Clinical Trial Quote Request
• Protocol and Informed Consent Form in English
• Local CRO details (Contact Person Name, Address, Telephone Number and E-mail Address)
• Completed, signed and dated Clinical Trial Proposal form (To be provided separately)
• Provide completed Anti-Money Laundering document which is required (To be provided separately)

- Regulatory Approval (RA) from the National Agency for Food & Drugs Administration and Control (NAFDAC), which can be provided after release of the policy documents, but is absolutely required unless the Sponsor does not have approval at the time of submission
- Nigeria requires a local quotation so the premium will be subject to change by the local Nigerian office
- Nigeria is a cash before cover country, which means Policy documents only released after premium payment received by the carrier; Sponsor pays the Carrier directly once invoice is provided and Carrier will confirm receipt of funds
- No refunds for policy cancellation